Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05236985 · ClinicalTrials.gov registry record · Phase 4
Oxytocin Bolus Versus Infusion in Elective Cesarean Section"
A Phase 4 study of Elective Cesarean Section, sponsored by Stony Brook University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05236985: Recruiting Phase 4 study of Elective Cesarean Section, sponsored by Stony Brook University.
NCT05236985 is a Phase 4 study of Elective Cesarean Section that is actively recruiting participants, run by Stony Brook University. The registered enrollment target is 120 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05236985, a Phase 4 study of Elective Cesarean Section, is actively recruiting participants, sponsored by Stony Brook University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Bolus administration of oxytocin is superior to infusion in time to achieving adequate uterine tone.
Conditions Studied
Interventions
- DRUG Oxytocin bolus or oxytocin infusion
Study Locations (1)
New York
- Stony Brook University - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-03-15 |
| Est. Completion | 2024-12-15 |
| Phase | Phase 4 |
What NCT05236985 shows while recruiting
NCT05236985 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Elective Cesarean Section appearing as the primary indexed condition, and to 1 intervention - of which Oxytocin bolus or oxytocin infusion is the first listed.
NCT05236985 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05236985 about?
NCT05236985 is a clinical study titled "Oxytocin Bolus Versus Infusion in Elective Cesarean Section"". Bolus administration of oxytocin is superior to infusion in time to achieving adequate uterine tone.
What is the current status of trial NCT05236985?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2022-03-15. Estimated completion is 2024-12-15.
What conditions does trial NCT05236985 study?
This clinical trial studies the following conditions: Elective Cesarean Section.
What interventions are being tested in trial NCT05236985?
The interventions under investigation include: Oxytocin bolus or oxytocin infusion (DRUG).
Who is sponsoring clinical trial NCT05236985?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05236985 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Elective Cesarean Section
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05236985's enrollment target sits among peer trials
120 673rd of 2000 higher than 1,290 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI